Prognostic Markers in Transcatheter Mitral Valve Repair

Authors

  • Michael Chrissoheris Ygeia Hospital, Athens, Greece

DOI:

https://doi.org/10.2015/hc.v9i1%20Sup.666

Keywords:

mitral valve, Mitral regurgitation, transcatheter mitral valve repair

Abstract

The Mitraclip procedure is at present the most widely available method for transcatheter correction of severe mitral regurgitation (MR). The efficacy and the safety of the device has been evaluated in the EVEREST II randomized control study1 (head to head comparison with traditional surgical repair or replacement of the mitral valve) and although not as effective in abolishing MR, it provided significant improvement in functional class, along with evidence of favorable ventricular remodeling and with low perioperative morbidity and mortality.

 

Downloads

Published

2014-06-02

Issue

Vol. 9 No. 1 Sup (2014): ATHENS CARDIOLOGY UPDATE 2014

Section

ATHENS CARDIOLOGY UPDATE 2014

License

Authors who publish with this journal agree to the following terms:

a. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).